Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'ABL-POSITIVE CELLS' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 32 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Druker, BJ
      Current treatment approaches for chronic myelogenous leukemia

      CANCER JOURNAL
    2. Campbell, JDM; Cook, G; Holyoake, TL
      Evolution of bone marrow transplantation - the original immunotherapy

      TRENDS IN IMMUNOLOGY
    3. Krystal, GW
      Mechanisms of resistance to imatinib (ST1571) and prospects for combination with conventional, chemotherapeutic agents

      DRUG RESISTANCE UPDATES
    4. Weisberg, E; Griffin, JD
      Mechanisms of resistance imatinib (ST1571) in preclinical models and in leukemia patients

      DRUG RESISTANCE UPDATES
    5. Mauro, MJ; Druker, BJ
      Chronic myelogenous leukemia

      CURRENT OPINION IN ONCOLOGY
    6. Brouard, MC; Prins, C; Mach-Pascual, S; Saurat, JH
      Acute generalized exanthematous pustulosis associated with STI571 in a patient with chronic myeloid leukemia

      DERMATOLOGY
    7. O'Dwyer, ME; Druker, BJ
      Chronic myelogenous leukaemia - new therapeutic principles

      JOURNAL OF INTERNAL MEDICINE
    8. Miyamoto, N; Sugita, K; Goi, K; Inukai, T; Iijima, K; Tezuka, T; Kojika, S; Nakamura, M; Kagami, K; Nakazawa, S
      The JAK2 inhibitor AG490 predominantly abrogates the growth of human B-precursor leukemic cells with 11q23 translocation or Philadelphia chromosome

      LEUKEMIA
    9. Hochhaus, A; Lahaye, T; Kreil, S; Berger, U; Metzgeroth, G; Hehlmann, R
      Selective inhibition of tyrosine kinases - a new therapeutic principle in oncology

      ONKOLOGIE
    10. Mauro, MJ; O'Dwyer, ME; Druker, BJ
      ST1571, a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia: validating the promise of molecularly targeted therapy

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    11. Ergin, M; Denning, MF; Izban, KF; Amin, HM; Martinez, RL; Saeed, S; Alkan, S
      Inhibition of tyrosine kinase activity induces caspase-dependent apoptosisin anaplastic large cell lymphoma with NPM-ALK (p80) fusion protein

      EXPERIMENTAL HEMATOLOGY
    12. Jorgensen, HG; Holyoake, TL
      A comparison of normal and leukemic stem cell biology in chronic myeloid leukemia

      HEMATOLOGICAL ONCOLOGY
    13. Drummond, MW; Holyoake, TL
      Tyrosine kinase inhibitors in the treatment of chronic myeloid leukaemia: so far so good?

      BLOOD REVIEWS
    14. Mahon, FX
      Chronic myelogenous leukemic and tyrosine kinase inhibitors.

      REVUE DE MEDECINE INTERNE
    15. Traxler, P; Bold, G; Buchdunger, E; Caravatti, G; Furet, P; Manley, P; O'Reilly, T; Wood, J; Zimmermann, J
      Tyrosine kinase inhibitors: From rational design to clinical trials

      MEDICINAL RESEARCH REVIEWS
    16. Marley, SB; Davidson, RJ; Lewis, JL; Nguyen, DX; Eades, A; Parker, S; Goldman, JM; Gordon, MY
      Progenitor cells from patients with advanced phase chronic myeloid leukaemia respond to STI571 in vitro and in vivo

      LEUKEMIA RESEARCH
    17. Druker, B
      Signal transduction inhibition: Results from phase I clinical trials in chronic myeloid leukemia

      SEMINARS IN HEMATOLOGY
    18. Lyseng-Williamson, K; Jarvis, B
      Imatinib

      DRUGS
    19. Etienne, G; Mahon, FX
      Leukemogenesis and new therapy development: the example of chronic myelogenous leukemia

      BULLETIN DU CANCER
    20. Wolff, NC; Ilaria, RL
      Establishment of a murine model for therapy-treated chronic myelogenous leukemia using the tyrosine kinase inhibitor STI571

      BLOOD
    21. Kano, Y; Akutsu, M; Tsunoda, S; Mano, H; Sato, Y; Honma, Y; Furukawa, Y
      In vitro cytotoxic effects of a tyrosine kinase inhibitor STI571 in combination with commonly used antileukemic agents

      BLOOD
    22. Donato, NJ; Talpaz, M
      Clinical use of tyrosine kinase inhibitors: Therapy for chronic myelogenous leukemia and other cancers

      CLINICAL CANCER RESEARCH
    23. Krystal, GW; Honsawek, S; Litz, J; Buchdunger, E
      The selective tyrosine kinase inhibitor STI571 inhibits small cell lung cancer growth

      CLINICAL CANCER RESEARCH
    24. Waller, CF; Ali, M; Heinzinger, M; Lange, W
      Growth inhibition of Ph+ progenitor cells from CML patients using the tyrosine kinase inhibitor CGP57148B

      ANTICANCER RESEARCH
    25. Goldman, JM
      Tyrosine-kinase inhibition in treatment of chronic myeloid leukaemia

      LANCET
    26. Schrock, E; Padilla-Nash, H
      Spectral karyotyping and multicolor fluorescence in situ hybridization reveal new tumor-specific chromosomal aberrations

      SEMINARS IN HEMATOLOGY
    27. le Coutre, P; Tassi, E; Varella-Garcia, M; Barni, R; Mologni, L; Cabrita, G; Marchesi, E; Supino, R; Gambacorti-Passerini, C
      Induction of resistance to the Abelson inhibitor ST1571 in human leukemic cells through gene amplification

      BLOOD
    28. Sawyers, CL; Druker, B
      Tyrosine kinase inhibitors in chronic myeloid leukemia

      CANCER JOURNAL FROM SCIENTIFIC AMERICAN
    29. Traxler, P; Furet, P
      Strategies toward the design of novel and selective protein tyrosine kinase inhibitors

      PHARMACOLOGY & THERAPEUTICS
    30. Carlo-Stella, C; Regazzi, E; Sammarelli, G; Colla, S; Garau, D; Gazit, A; Savoldo, B; Cilloni, D; Tabilio, A; Levitzki, A; Rizzoli, V
      Effects of the tyrosine kinase inhibitor AG957 and an anti-Fas receptor antibody on CD34(+) chronic myelogenous leukemia progenitor cells

      BLOOD
    31. Faderl, S; Talpaz, M; Estrov, Z; Kantarjian, HM
      Chronic myelogenous leukemia: Biology and therapy

      ANNALS OF INTERNAL MEDICINE
    32. Traxler, P
      Tyrosine kinase inhibitors in cancer treatment (part II)

      EXPERT OPINION ON THERAPEUTIC PATENTS


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 06/06/20 alle ore 11:18:38